Effect of pregnancy on the pharmacokinetics of metformin
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aims To determine the effects of pregnancy on metformin pharmacokinetics. Methods Seven women with Type 2 diabetes mellitus taking metformin throughout pregnancy were studied on two occasions, once at 28–36 weeks gestation and once at least 8 weeks postpartum. Serum metformin concentrations were determined across a dosing interval using high‐performance liquid chromatography. The areas under the serum concentration‐time curve from 0 to 4 h post‐dose (AUC 0−4) and 0 to 8 h post‐dose (AUC 0−8) where possible, were compared in the pregnant and non‐pregnant state. Results Metformin concentrations were lower in pregnancy in six subjects, with a mean (95% CI) AUC 0−4 that was 69% (53.6, 84.8) of the postpartum value. The AUC 0−4 of one subject was higher in pregnancy at 142% of the postpartum value. Overall, the mean (95% CI) AUC 0−4 during pregnancy for all seven subjects was 80% (51.3, 107.8) of the postpartum value (P = 0.053, two‐tailed t‐test; P = 0.027, one‐tailed t‐test). Conclusion These results are consistent with our hypothesis that the clearance of metformin increases in pregnancy as a result of enhanced renal elimination. A larger study is required to establish whether metformin dose adjustments are required in late pregnancy to maintain therapeutic effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
Wang, D.-S., Jonker, J. W., Kato, Y., Kusuhara, H., Schinkel, A. H., & Sugiyama, Y. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034140 · Cited by 441
Cited by
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
“Increasing dosage during pregnancy and reducing dosage back to usual levels after delivery should be considered.([54]) There is minimal transport of metformin into milk with the estimated dose being less than 0.”
BackgroundThompson, D., Berger, H., Feig, D., Gagnon, R., Kader, T., Keely, E., Kozak, S., Ryan, E., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.044 · Cited by 377
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review
Pariente, G., Leibson, T., Carls, A., Adams-Webber, T., Ito, S., & Koren, G. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002160 · Cited by 336
Isoherranen, N., & Thummel, K. E. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050245 · Cited by 239
“, 2009) OCT2 Metformin ↔ ↑ ↔↑ (Hughes et al., 2006; Eyal et al., 2010; de Oliveira Baraldi et al., 2011) OAT1 Zidovudine, lamivudine ↔ (Moodley et al.”
Pharmacokinetics of metformin during pregnancy
Eyal, S., Easterling, T. R., Carr, D., Umans, J. G., Miodovnik, M., Hankins, G. D. V., Clark, S. M., Risler, L., Wang, J., Kelly, E. J., et al. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031245 · Cited by 209
Metadata
- Authors
- Hughes, R. C. E., Gardiner, S. J., Begg, E. J., & Zhang, M.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2006-02-16
- Volume
- 23
- Issue
- 3
- Pages
- 323-326
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1985141616
- Cited by
- 54
- References
- 2
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of pregnancy on the pharmacokinetics of metformin. https://app.cochat.ai/papers/10.1111/j.1464-5491.2005.01769.x
- The paper
- Hughes, R. C. E., Gardiner, S. J., Begg, E. J., & Zhang, M. (2006). Effect of pregnancy on the pharmacokinetics of metformin. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2005.01769.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.